Are you a new member? Sign up now
Login area
| Sign up
close
OMNICEF - 125mg/5ml - 40ml
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| J01DD15 | B | Cefdinir - 125mg/5ml | 8841 | 87116/1 | OMNICEF | 125mg/5ml | 40ml | Powder for suspension | Oral | Droguerie de l'Union | Jazeera Pharmaceutical Industries | Saudi Arabia | 1,189,301 L.L | 23.08 | A2 | Hikma Pharmaceuticals | Jordan | 2/4/2025 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| J01DD15 | B | Cefdinir - 125mg/5ml | 3560 | 148399/04 | OMNICEF | 125mg/5ml | 40ml | Powder for suspension | Oral | Droguerie de l'Union | Hikma Pharmaceuticals under license of Astellas Pharma Inc Japan | Jordan | 1,189,301 L.L | 23.08 | A2 | 2/4/2025 | |||
| J01DD15 | B | Cefdinir - 125mg/5ml | 3561 | 195098/04 | OMNICEF | 125mg/5ml | 80ml | Powder for suspension | Oral | Droguerie de l'Union | Hikma Pharmaceuticals under license of Astellas Pharma Inc Japan | Jordan | 2,025,171 L.L | 23.08 | B | 2/4/2025 | |||
| J01DD15 | B | Cefdinir - 125mg/5ml | 8840 | 87016/1 | OMNICEF | 125mg/5ml | 80ml | Powder for suspension | Oral | Droguerie de l'Union | Jazeera Pharmaceutical Industries under licence of Astellas Pharma Inc Japan | Saudi Arabia | 2,025,171 L.L | 23.08 | B | Hikma Pharmaceuticals | Jordan | 2/4/2025 | |
| J01DD15 | G | Cefdinir - 125mg/5ml | 7910 | 31414/1 | SEFARIN | 125mg/5ml | 100ml | Suspension | Oral | Picomed SARL | Pharma International Co Ltd | Jordan | 1,695,929 L.L | 23.08 | B | Pharma International Co Ltd | Jordan | 2/4/2025 | |
| J01DD15 | G | Cefdinir - 125mg/5ml | 8227 | 50715/1 | SEFARIN | 125mg/5ml | 50ml | Suspension | Oral | Picomed SARL | Pharma International Co Ltd | Jordan | 939,346 L.L | 23.08 | A2 | Pharma International Co Ltd | Jordan | 2/4/2025 | |
| J01DD15 | G | Cefdinir - 125mg/5ml | 11910 | 104120/1 | XAVENEER | 125mg/5ml | 80ml | Powder for suspension | Oral | Sadco | Dar Al Dawa Development & Investment Co Ltd | Jordan | 1,308,903 L.L | 23.08 | A2 | Dar Al Dawa Development & Investment Co Ltd | Jordan | 2/4/2025 | |
| J01DD15 | G | Cefdinir - 125mg/5ml | 11911 | 104020/1 | XAVENEER | 125mg/5ml | 40ml | Powder for suspension | Oral | Sadco | Dar Al Dawa Development & Investment Co Ltd | Jordan | 686,704 L.L | 23.08 | A1 | Dar Al Dawa Development & Investment Co Ltd | Jordan | 2/4/2025 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2025